Publication | Open Access

PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab

Pher2 ExpressionBreast OncologyMedicineAdjuvant ChemotherapyPik3ca MutationsBreast CancerCancer TreatmentCancer GeneticsRadiation OncologyOncologyCell Biology